Krill Oil for Osteoarthritis

Krill oil probably helps knee osteoarthritis only a little, if at all: it has been tested in several randomised trials, and the two biggest disagree. In 235 adults with mild to moderate knee osteoarthritis, 4 g a day for 6 months improved WOMAC pain by 5.18 points more than placebo on a 0-100 scale, with similar small gains in stiffness and function [2]. In 262 adults with significant knee pain and joint inflammation on MRI, 2 g a day for 24 weeks made no difference: pain fell by 19.9 points on krill oil and 20.2 on placebo [1].

Meta-analyses of five or six trials pull in different directions on pain, but all three found some improvement in physical function, small in the strictest analysis [6][7][8]. So the realistic expectation is a small effect at best, and possibly none for pain. Large improvements seen in people taking krill oil were matched almost exactly by placebo in the JAMA trial [1].

Krill oil provides the long-chain omega-3 fats EPA and DHA, the same fats as fish oil, along with astaxanthin, an antioxidant pigment [2]. The rationale is anti-inflammatory: osteoarthritis pain is partly driven by inflammation of the joint lining, and the JAMA trial specifically recruited people with effusion-synovitis, fluid and inflamed lining visible on MRI [1].

Krill oil reliably raises omega-3 levels. In the 6-month knee trial the omega-3 index rose from 6.0% to 8.9% on krill oil, with no change on placebo [2], and a network meta-analysis found krill oil raised omega-3 levels more than fish oil at doses under 2,000 mg [10]. For the wider picture of omega-3 and joints, see omega-3 for joint pain.

A higher omega-3 level is not the same as less pain. In the 6-month trial, inflammatory markers did not differ between groups despite the rise in omega-3 [2], and a 2026 meta-analysis found no effect on CRP [8]. The JAMA trial chose the people most likely to respond, those with inflamed joint linings, and still saw no benefit for pain [1].

Better absorption than fish oil is also a blood-level finding [10]. No trial has compared krill oil with fish oil for osteoarthritis symptoms, and no human trial has shown that krill oil protects cartilage.

Doses varied widely. The positive 6-month trial used 4 g of krill oil a day, supplying 0.60 g EPA and 0.28 g DHA, in adults aged 40-65 who ate less than 0.5 g of long-chain omega-3 a day [2]. The null JAMA trial used 2 g a day for 24 weeks [1]. A 30-day Japanese trial in mild knee pain also used 2 g a day [3], and an early 30-day trial used 300 mg a day [4].

No trial compared doses of krill oil directly, so it is not known whether 4 g works better than 2 g. In a 2-year fish oil trial, a high dose (4.5 g omega-3 a day) was no better than a low dose (0.45 g) for knee pain [9].

Stonehouse and colleagues randomised 235 adults aged 40-65 with mild to moderate knee osteoarthritis and low omega-3 intake to 4 g of krill oil a day or a vegetable oil placebo for 6 months [2]. Knee pain improved in both groups, but more with krill oil (adjusted difference -5.18 points on a 0-100 scale, 95% CI -10.0 to -0.32, P=0.04), as did stiffness (-6.45) and physical function (-4.67) [2]. NSAID use did not differ between groups [2].

Laslett and colleagues ran a larger trial in 5 Australian cities: 262 adults with knee osteoarthritis, significant knee pain and effusion-synovitis on MRI took 2 g of krill oil a day or placebo for 24 weeks [1]. Pain fell by 19.9 points with krill oil and 20.2 with placebo (difference -0.3, 95% CI -6.9 to 6.4), against a minimum clinically important improvement of 15 points; 85% completed the trial [1]. The authors concluded the findings do not support krill oil for knee pain in this group [1].

In 50 Japanese adults with mild knee pain, 2 g a day for 30 days improved pain when sleeping and standing and knee range of motion more than placebo after adjustment, although both groups improved on the overall questionnaires [3]. An earlier 30-day trial in 90 people with raised CRP and osteoarthritis, rheumatoid arthritis or heart disease found 300 mg a day cut CRP by 30.9% and reduced WOMAC scores [4]; it was a single-author study in a mixed population.

A 12-week trial of a combination of krill oil, astaxanthin and hyaluronic acid in 100 people with mild knee or hip osteoarthritis found greater pain reduction than placebo among the 75 analysed per protocol (20.8 vs 10.6 mm) [5]. Because the product had three active ingredients, it can't show what krill oil does on its own.

Three meta-analyses pooled mostly the same trials and disagree on pain. One, with trial sequential analysis of 5 trials and 700 patients, found no effect on pain or stiffness and a small benefit for physical function (SMD -0.24), and judged krill oil not yet justified for knee pain [6]. Another, of 5 trials and 730 participants, found no effect on VAS pain but benefits on WOMAC pain, stiffness and function [7]. A 2026 analysis of 6 trials and 971 participants found WOMAC pain and function improved at week 4 [8].

In a network meta-analysis of 39 trials comparing seven supplements for knee osteoarthritis, boswellia ranked most likely to be best for pain and stiffness; krill oil showed potential mainly for function [17]. See boswellia for osteoarthritis for that evidence. Across all marine oils, a meta-analysis found a pain benefit in rheumatoid arthritis but not in osteoarthritis (5 trials, SMD -0.17, not significant) [11].

No trial has compared krill oil with fish oil, with an anti-inflammatory gel, or between doses in osteoarthritis. Among the trials described here, none tested krill oil alone in hip or hand osteoarthritis, and none lasted longer than 6 months. No trial has measured cartilage as a main outcome.

Long-term data on omega-3 more broadly are not encouraging: in a VITAL substudy of 1,398 older adults with chronic knee pain, marine omega-3 supplements for a mean of 5.3 years did not reduce knee pain or improve function or stiffness [18].

Krill oil was well tolerated in the knee trials. In the JAMA trial, 51% reported at least one adverse event on krill oil and 54% on placebo, most often musculoskeletal complaints [1]. The 6-month trial found no differences in safety markers or blood lipids [2], and the meta-analyses found no difference in adverse events from placebo [7][8].

The wider omega-3 risks come from large cardiovascular trials. A meta-analysis of 11 trials (120,643 patients) found no overall increase in bleeding, although high-dose purified EPA raised the relative risk by 50%, an absolute increase of 0.6% [14]. Another linked marine omega-3 supplements to a 25% higher risk of atrial fibrillation, greater in trials using more than 1 g a day [15].

Krill oil is an add-on, not a replacement. The OARSI guidelines make education and structured land-based exercise, with or without dietary weight management, the core treatments for knee osteoarthritis, and strongly recommend topical anti-inflammatory gels [13]. The American College of Rheumatology guideline strongly recommends exercise, weight loss for people who are overweight, self-management programmes, tai chi, a cane and knee bracing where suitable [12].

The interactions worth knowing are the general omega-3 ones. People with osteoarthritis often take anti-inflammatory painkillers or aspirin, and anyone on a blood thinner should check with their prescriber, because high-dose EPA has been linked to more bleeding [14]. Higher omega-3 doses also carry a higher risk of atrial fibrillation [15].